KR970000234A - 디하이드로에보디아민-hc1를 유효성분으로 함유하는 기억항진 및 치매 치료제 - Google Patents

디하이드로에보디아민-hc1를 유효성분으로 함유하는 기억항진 및 치매 치료제 Download PDF

Info

Publication number
KR970000234A
KR970000234A KR1019960022298A KR19960022298A KR970000234A KR 970000234 A KR970000234 A KR 970000234A KR 1019960022298 A KR1019960022298 A KR 1019960022298A KR 19960022298 A KR19960022298 A KR 19960022298A KR 970000234 A KR970000234 A KR 970000234A
Authority
KR
South Korea
Prior art keywords
dihydroebodiamine
medications
dementia
memory
active ingredient
Prior art date
Application number
KR1019960022298A
Other languages
English (en)
Other versions
KR100203456B1 (ko
Inventor
서유헌
강삼식
김성훈
박철형
웅 최
Original Assignee
서유헌
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서유헌 filed Critical 서유헌
Publication of KR970000234A publication Critical patent/KR970000234A/ko
Application granted granted Critical
Publication of KR100203456B1 publication Critical patent/KR100203456B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019960022298A 1995-06-20 1996-06-19 디하이드로에보디아민-에이치씨1를 유효성분으로 함유하는 알츠하이머병에 의한 치매 치료제 KR100203456B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR101995016426 1995-06-20
KR19950016426 1995-06-20

Publications (2)

Publication Number Publication Date
KR970000234A true KR970000234A (ko) 1997-01-21
KR100203456B1 KR100203456B1 (ko) 1999-06-15

Family

ID=19417587

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960022298A KR100203456B1 (ko) 1995-06-20 1996-06-19 디하이드로에보디아민-에이치씨1를 유효성분으로 함유하는 알츠하이머병에 의한 치매 치료제

Country Status (3)

Country Link
US (1) US5859016A (ko)
JP (1) JP2906339B2 (ko)
KR (1) KR100203456B1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990036207A (ko) * 1996-06-12 1999-05-25 히라타 다다시 지질대사 개선제
KR100540369B1 (ko) * 2001-11-29 2006-01-11 주식회사 두산 (-)에페갈로카테킨 갈레이트 화합물을 포함하는 중증 무력증, 위장관과 방광평활근 무력증 및 녹내장 질환의 치료 또는 예방용 약학적 제제와 기억력 촉진를 위한 약학적 제제
CN1309389C (zh) * 2005-01-12 2007-04-11 贵州省中国科学院天然产物化学重点实验室 具有乙酰胆碱酯酶抑制活性组合物及其制备方法和应用
US20100028839A1 (en) * 2008-07-18 2010-02-04 Tully Timothy P Methods and systems for evaluating memory agents
CN101829117A (zh) * 2010-05-05 2010-09-15 中国医学科学院实验动物研究所 吴茱萸碱在制备治疗阿尔茨海默病的药物中的应用
KR101418545B1 (ko) * 2012-11-16 2014-07-10 주식회사 브레인트로피아 카르복시 디하이드로 에보다이아민을 포함하는 퇴행성 신경계 뇌 질환의 예방 또는 치료용 약학 조성물
TWI480496B (zh) 2013-11-20 2015-04-11 Ind Tech Res Inst 通電直熱再生式壓縮空氣乾燥裝置及除濕再生單元
AU2018330578B2 (en) * 2017-09-07 2022-11-10 Eisai R&D Management Co., Ltd. Pentacyclic compound
KR20210135223A (ko) 2019-03-05 2021-11-12 에자이 알앤드디 매니지먼트 가부시키가이샤 펜타시클릭 화합물의 염 및 이의 결정
AR118235A1 (es) * 2019-03-05 2021-09-22 Eisai R&D Man Co Ltd Heterociclos pentacíclicos
KR102435727B1 (ko) * 2020-05-15 2022-08-23 가천대학교 산학협력단 알츠하이머 질환의 글루코스 대사 조절제 및 이를 스크리닝하는 방법

Also Published As

Publication number Publication date
US5859016A (en) 1999-01-12
JP2906339B2 (ja) 1999-06-21
KR100203456B1 (ko) 1999-06-15
JPH09118621A (ja) 1997-05-06

Similar Documents

Publication Publication Date Title
HUP9602601A3 (en) Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
DE69630012D1 (de) Zeitverschobener bedingter zugang
DE69609862D1 (de) Datenbasiszugriff
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
DE69513671D1 (de) Arzneimittel
DE3876415D1 (de) Dynamischer direktzugriffsspeicher.
DE69624739D1 (de) Aktiv-Puls-Magnetometer
NO981008D0 (no) Farmasöytisk formulering
KR970000234A (ko) 디하이드로에보디아민-hc1를 유효성분으로 함유하는 기억항진 및 치매 치료제
BR9600809A (pt) Medicamento
DE69300566D1 (de) Verpackung.
DE59609922D1 (de) Wirkstoffkombinationen
FI955605A0 (fi) Aryloivia lääkkeitä
DE19680282D2 (de) Tabletten-Verpackungsschachtel
TR199601018A1 (tr) Farmasötik bilesikler.
FR2688759B1 (fr) Conditionnement double.
AU4318397A (en) Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
KR970000225A (ko) 시네프린을 유효성분으로 함유하는 우울증 치료제
DE19681206T1 (de) DRAM-Emulator
KR970008018U (ko) 장제용 위패
FI940113A0 (fi) Aktiivinastajärjestelmä
ES1031411Y (es) Embalaje.
UA1038S (uk) Пляшка для зберігання препаратів

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130228

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20140124

Year of fee payment: 16

FPAY Annual fee payment

Payment date: 20160323

Year of fee payment: 18

EXPY Expiration of term